A promising platform for predicting toxicity

Area of Science:

• Biomedical Engineering
• Pharmacology
• Oncology

Background:

• Cancer immunotherapies harness the immune system to fight cancer but can cause severe side effects.
• Predicting drug toxicity is crucial for patient safety and effective treatment development.
• Current toxicity testing methods have limitations in accurately reflecting human responses.

Purpose of the Study:

• To evaluate the potential of organ-on-chip technology for predicting cancer immunotherapy drug toxicity.
• To explore how microphysiological systems can enhance preclinical safety assessments.

Main Methods:

• Utilizing advanced organ-on-chip models that mimic human organ functions.
• Testing the toxicological profiles of various cancer immunotherapy agents on these models.

Main Results:

• Organ-on-chip systems demonstrated the ability to identify specific toxicities associated with immunotherapies.
• Results showed a higher correlation with clinical toxicity data compared to traditional methods.

Conclusions:

• Organ-on-chip technology presents a viable and potentially more accurate method for assessing immunotherapy drug safety.
• This approach could significantly improve the prediction of adverse events, aiding in the development of safer cancer treatments.